Klaus Maleck News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ITM Appoints Dr Mark Harfensteller as Member of its Executive Board

ITM Appoints Dr Mark Harfensteller as Member of its Executive Board
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Steffen schusterKlaus maleckMark harfenstellerBen orzelekSebastian marxA societas europaeaGerrit siegersTechnical university of munichCorporate communicationsGroup as head of engineeringInstitute of machine toolsCanadian nuclear laboratoriesChief operating officerManaging directorIsotopes gmbhGood manufacturing practice

ITM Isotope Technologies Munich SE: ITM Appoints Dr Mark Harfensteller as Member of its Executive Board

ITM Isotope Technologies Munich SE: ITM Appoints Dr Mark Harfensteller as Member of its Executive Board
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

A societas europaeaSteffen schusterGerrit siegersKlaus maleckMark harfenstellerSebastian marxBen orzelekActineer incTechnical university of munichCanadian nuclear laboratoriesInstitute of machine toolsCorporate communicationsTechnologies munichChief executive officerChief financial officerChief business officer

ITM Appoints Dr Mark Harfensteller as Member of its

Garching / Munich, Germany, January 16, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced the.

Gerrit siegersA societas europaeaSebastian marxSteffen schusterBen orzelekMark harfenstellerKlaus maleckCanadian nuclear laboratoriesTechnical university of munichCorporate communicationsGroup as head of engineeringInstitute of machine toolsChief operating officerManaging directorIsotopes gmbhGood manufacturing practice

ITM to Present at the 42nd Annual J P Morgan Healthcare Conference

Garching / Munich, Germany, December 21, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that CEO, Steffen Schuster and CFO, Dr. Klaus Maleck

San franciscoUnited statesBen orzelekSteffen schusterKlaus maleckGerrit siegersCorporate communicationsTechnologies munichHealthcare conference

Investegate |ITM Isotope Technologies Munic Announcements | ITM Isotope Technologies Munic: ITM Signs Clinical Supply Agreement with Y-mAbs for n c a Lutetium-177

Investegate announcements from ITM Isotope Technologies Munic, ITM Signs Clinical Supply Agreement with Y-mAbs for n.c.a. Lutetium-177

Valeria fisherBen orzelekSteffen schusterJulia hofmann susanne karlssonLu endolucinbetaUdoj vetterCorporate communicationsY mabs therapeutics incDistrict courtTrophic communicationsDeutsche bank freiburgPharma solutions gmbClinical supply agreementY mab targeted radionuclide therapyTechnologies munichY mabs therapeutics